Osteoarticular InfectionsMOLOSNCT01193803
Molecular Microbiology in Osteo-arthritis Infection
An observational study of Osteoarticular Infections, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Osteoarticular Infections
- What is being tested?
- Microbiological cultures and Molecular biology
- Type of treatment
- Vaccines, Surgery or procedure
- How many people
- 229 participants
- Where
- 1 siteFrance
- Study dates
- Oct 2008to Jun 2012
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Suspected diagnosis of osteoarticular infections included discitis, septic arthritis and prosthetic joint infection and control patients.
Who may be able to join
- Patient are more than 18 years old
- Patient who do not declined to have his medical records reviewed for research
- Spondylodiscitis (S) group:
- Patients suspected of Discitis and/or Vertebral Osteomyelitis is defined by the need of spinal biopsy in infectious context. Spinal biopsies will be justified by one or more clinical or imaging findings:
- Clinical presentation
- Spinal pain unrelieved by rest
Show all 39Show fewer
- Localized tenderness, Neurological deficits or limited range of motion
- Fever > 38°C
- Imaging findings (plain radiographs, MRI or CT):
- Erosions of end plates on adjacent vertebral bodies
- Decreased height of the intervertebral disk
- Presence of a nonvascularized zone suggesting presence of pus or necroses in intervertebral, epidural space or in paraspinal soft-tissues
- Prosthetic Joint Infection (PJI) Group
- Patients suspected of Prosthetic Joint Infection were defined by the need of surgical revision for diagnostic or therapeutic aiming in infectious context. This revision will be justified by one or more clinical, biological or imaging findings:
- Clinical presentation
- Persistent joint pain
- Fever > 38°C
- Erythematous, swollen, fluctuant, and/or tender surgical wound
- Wound dehiscence
- Limited range of joint motion
- Biological findings
- CRP > 10 mg/l
- Synovial leukocytes count > 1500/mm3 and polymorphonuclear leukocytes > 65%
- Imaging findings
- Prosthesis loosening: Periprosthetic osteolysis, progressive peri-prosthetic edging
- Scintigraphy by means of a technetium (Tc99m) scan, gallium citrate (Ga67) scan, or indium (In111)-labeled leukocyte showing fixation around the prosthesis.
- Septic arthritis (SA) Group
- Patients suspected of Septic arthritis without prosthesis were defined by the need of synovial punction and/or biopsy justified by one or more clinical, biological or imaging findings:
- Clinical presentation
- Acute joint pain and/or swelling
- Adenopathy near inflammatory joint
- Fever > 38°CBiological findings
- WBC > 10 000/ mm3
- CRP > 10 mg/l
- Synovial leukocytes count > 2000/mm3 or polymorphonuclear leukocytes > 90%
- Imaging findings:
- Capsular and surrounding soft-tissues swelling
- Synovial notch and/or demineralization
- Periarticular Abscess
Who cannot join
- Patients already include.
- Patient without health insurance
- Antibiotic treatment before sampling does not constitute an exclusion criterion
- Patient with one or more criteria:
- Suspicion of concomitant infection defined by a fever >38°C and CRP > 10mg/l
- Arthrosis treated by infiltration in the 6 months which preceding inclusion
- Rapidly progressive arthrosis Prosthesis loosening or bone necrosis presumed to be aseptic
- Patients with prior spinal instrumentation or surgery
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Interest of Molecular Biology for Diagnostic of Osteo-arthritis Infections. EE Observational Prospective Study
Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria. However, the sensitivity of these cultures is very variable and depends both on the context in which clinical samples are taken, and on the pathogen involved. The rate of detection varies according to infection type: from 50 to 70% for infectious spondylodiscitis, 65 to 95% for prosthetic joint infections, 50% for gonococcal arthritis and 90% for non-gonococcal arthritis. The aim of the study is to evaluate the diagnostic performances of microbiological cultures and molecular methods in case of osteoarticular infections. The gold standard will be established by an expert group of osteoarticular infection (composed by a bacteriologist, a radiologist, a surgeon, an anatomy-pathologist and a rheumatologist), which established the final diagnosis of infected or not infected patients.
Read the detailed description
Background: Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria and it seems that the microbiological cultures are sufficient in most cases to establish the diagnosis. However, the sensitivity of these cultures is very variable and depends both on the context in which clinical samples are taken, and on the pathogen involved. In addition, previous experimental data show that molecular methods could produce a diagnosis missing by conventional cultures. Main objective: The aim of the study is to evaluate the diagnostic performances of microbiological cultures and molecular method by considering for the definition of cases an accumulation of clinical, radiological and biological arguments usually used to establish the diagnosis of bone and joint infections. The discordance of the two methods will be secondary classified by an expert group of osteoarticular infection (composed by a bacteriologist, a radiologist, a surgeon, a anatomy-pathologist and a rheumatologist).Tested hypothesis:Interest of molecular methods for the diagnosis of osteoarticular infections.Secondary objective:Quantification of the delay of the results obtained by the two methods Study design: · One centre specialized in osteoarticular infections· Observational prospective study· Two methods of diagnosis: cultures and molecular methods· An expert group Included patients and number of patients: Total of 284 patients composed by 194 cases and 90 controlsIncluded patients (n=194) will all have a suspected diagnosis of osteoarticular infections included discitis, septic arthritis and prosthetic joint infection defined by inclusions criteria.Results of the included patients will be compared to those obtained from the group of control patients (n=90).Protocol of duration: Study duration is 6 months for each patientThe protocol duration is planned for 2 yearsProcedures:All samples will be treated with the same procedure - Samples (synovial fluids, biopsies, ..) will be recovered either during surgery, by puncture aspiration at the bedside, or by guided ultrasonography, all under sterile conditions (mask, sterile gloves, cautious skin preparation and towelling) and transported to the Bacteriology department in sterile tubes without additional substrate in less than 12 hours. - Bacteriological procedures will be performed according to the guidelines applied for osteoarticular infection · Liquid samples: erythrocyte and leukocyte counts, polymorphonuclear percentage · Solid specimens: crushed using a mechanic apparatus · Gram and auramine staining· Cultures at 37°C on Columbia sheep blood agar (aerobically and anaerobically for 5 days), chocolate agar supplemented with IsoVitaleX (with 5% CO2 for 5 days), brain heart infusion broth (anaerobically for 15 days with subcultures done after 10 days on the same agar media, even if aspect was not cloudy).· Mycobacterial culture : Lowenstein-Jensen and COLETSOS media, MGIT incubated for 3 months.- Molecular procedures· DNA manipulations pre- and post-PCR: in separate rooms with separate pipetting devices to prevent contamination of samples with foreign DNA. · Equipment used in pre-PCR steps: DNA-free and UV-irradiated. · DNA extraction based on Boom's method: QIAGEN kit and EZ1 BioRobot · Broad-range 16S rRNA gene amplification · Amplicons: sequenced in both directions on an ABIPRISM 3100 analyser (Applied Bio systems, COURTABOEUF, France). · Cloning experiments for several sequences in one sample· Analysis of sequence: GenBank using the BLASTN program through the website of the National Centre of Biotechnology Information.· Internal control PCR: b-actin gene· Real time PCR: for the detection of mycobacteria and gonococcal arthritis- Potential implications: We could have chosen, like the majority of the studies published to date, to compare our molecular method with another method of diagnosis (culture, histology). However, there is not currently gold standard and the diagnosis of osteoarticular infections generally rests on an accumulation of arguments. The rule of the expert group is to determine, with less possible error, if each patient included will be "infected". This methodology is close to daily clinical reality and trusted in physician who was treating the patient. If the study shows an advantage of the molecular biology versus classical methods in our groups it would then be justified to discuss the diagnosis diagram of osteoarticular infections.
- Conditions
- Osteoarticular Infections
- Being tested
- Microbiological cultures and Molecular biology
- Keywords
- Prosthetic Joint Infections, Vertebral Osteomyelitis, Septic arthritis, Molecular methods
- Medical subject headings
- Arthritis, Infectious
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Microbiological cultures and Molecular biologyProcedure or surgery
Biological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria.
Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol.
| Study group | Role | What they receive |
|---|---|---|
| Spondylodiscitis control group | Patients needing vertebral biopsy looking for tumoral etiology Receives: Procedure: Microbiological cultures and Molecular biology | |
| Prosthetic Joint Infection control group | Patients with primary prosthetic arthrosis surgery Receives: Procedure: Microbiological cultures and Molecular biology | |
| Septic arthritis control group | Arthrosic patients needing evacuating articular punction with leucocytes infiltration less than 1000 /mm3 Receives: Procedure: Microbiological cultures and Molecular biology | |
| Spondylodiscitis case group | Patients suspected of Discitis and/or Vertebral Osteomyelitis is defined by the need of spinal biopsy in infectious context. Receives: Procedure: Microbiological cultures and Molecular biology | |
| Prosthetic Joint Infection case group | Patients suspected of Prosthetic Joint Infection defined by the need of surgical revision for diagnostic or therapeutic aiming in infectious context. Receives: Procedure: Microbiological cultures and Molecular biology | |
| Septic arthritis case group | Patients suspected of Septic arthritis without prosthesis were defined by the need of synovial punction and/or biopsy Receives: Procedure: Microbiological cultures and Molecular biology |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prosthetic Joint Infections, Vertebral Osteomyelitis and Septic arthritis: Frequency of detection with classical bacteriological methods and molecular methods
Measured: Day 0
Secondary outcomes (1)
Time of returned results by one or the other of the techniques
Measured: up to 90 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Sep 2010 (estimated)
- Study startOct 2008
- Primary completionDec 2011
- Study completionJun 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Osteoarticular InfectionsStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 229 participants (actual)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Beatrice BERCOT, MD,PhD, Principal investigator, Assistance Publique - Hôpitaux de Paris
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01193803
- Sponsor's protocol ID
- CRC076057
- Other IDs
- 297-08
- Acronym
- MOLOS
- Status last verified
- May 2014
- First submitted
- 1 Apr 2010
- Last updated
- 2 Jun 2014
- Results posted
- No
- Data monitoring committee
- No
Publications
Fihman V, Hannouche D, Bousson V, Bardin T, Liote F, Raskine L, Riahi J, Sanson-Le Pors MJ, Bercot B. Improved diagnosis specificity in bone and joint infections using molecular techniques. J Infect. 2007 Dec;55(6):510-7. doi: 10.1016/j.jinf.2007.09.001. Epub 2007 Oct 29.
PubMed 18029022
Study at a glance
From the registry record, last updated by the sponsor on 2 Jun 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Interest of Molecular Biology for Diagnostic of Osteo-arthritis Infections. EE Observational Prospective Study
- ClinicalTrials.gov ID
- NCT01193803
- Acronym / sponsor ID
- MOLOS / CRC076057
- Conditions
- Osteoarticular Infections
- Keywords
- Prosthetic Joint Infections, Vertebral Osteomyelitis, Septic arthritis, Molecular methods
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 229 participants (actual)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Study start
- Oct 2008
- Primary completion
- Dec 2011 (actual)
- Study completion
- Jun 2012 (actual)
- First posted
- 2 Sep 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria. However, the sensitivity of these cultures is very variable and depends both on the context in which clinical samples are taken, and on the pathogen involved. The rate of detection varies according to infection type: from 50 to 70% for infectious spondylodiscitis, 65 to 95% for prosthetic joint infections, 50% for gonococcal arthritis and 90% for non-gonococcal arthritis. The aim of the study is to evaluate the diagnostic performances of microbiological cultures and molecular methods in case of osteoarticular infections. The gold standard will be established by an expert group of osteoarticular infection (composed by a bacteriologist, a radiologist, a surgeon, an anatomy-pathologist and a rheumatologist), which established the final diagnosis of infected or not infected patients.
Detailed description
Background: Osteoarticular infections are painful and disabling diseases that require antimicrobial treatment adapted to the microorganisms implicated. Microbiological cultures are currently regarded as the reference for identification of pathogenic bacteria and it seems that the microbiological cultures are sufficient in most cases to establish the diagnosis. However, the sensitivity of these cultures is very variable and depends both on the context in which clinical samples are taken, and on the pathogen involved. In addition, previous experimental data show that molecular methods could produce a diagnosis missing by conventional cultures. Main objective: The aim of the study is to evaluate the diagnostic performances of microbiological cultures and molecular method by considering for the definition of cases an accumulation of clinical, radiological and biological arguments usually used to establish the diagnosis of bone and joint infections. The discordance of the two methods will be secondary classified by an expert group of osteoarticular infection (composed by a bacteriologist, a radiologist, a surgeon, a anatomy-pathologist and a rheumatologist).Tested hypothesis:Interest of molecular methods for the diagnosis of osteoarticular infections.Secondary objective:Quantification of the delay of the results obtained by the two methods Study design: · One centre specialized in osteoarticular infections· Observational prospective study· Two methods of diagnosis: cultures and molecular methods· An expert group Included patients and number of patients: Total of 284 patients composed by 194 cases and 90 controlsIncluded patients (n=194) will all have a suspected diagnosis of osteoarticular infections included discitis, septic arthritis and prosthetic joint infection defined by inclusions criteria.Results of the included patients will be compared to those obtained from the group of control patients (n=90).Protocol of duration: Study duration is 6 months for each patientThe protocol duration is planned for 2 yearsProcedures:All samples will be treated with the same procedure - Samples (synovial fluids, biopsies, ..) will be recovered either during surgery, by puncture aspiration at the bedside, or by guided ultrasonography, all under sterile conditions (mask, sterile gloves, cautious skin preparation and towelling) and transported to the Bacteriology department in sterile tubes without additional substrate in less than 12 hours. - Bacteriological procedures will be performed according to the guidelines applied for osteoarticular infection · Liquid samples: erythrocyte and leukocyte counts, polymorphonuclear percentage · Solid specimens: crushed using a mechanic apparatus · Gram and auramine staining· Cultures at 37°C on Columbia sheep blood agar (aerobically and anaerobically for 5 days), chocolate agar supplemented with IsoVitaleX (with 5% CO2 for 5 days), brain heart infusion broth (anaerobically for 15 days with subcultures done after 10 days on the same agar media, even if aspect was not cloudy).· Mycobacterial culture : Lowenstein-Jensen and COLETSOS media, MGIT incubated for 3 months.- Molecular procedures· DNA manipulations pre- and post-PCR: in separate rooms with separate pipetting devices to prevent contamination of samples with foreign DNA. · Equipment used in pre-PCR steps: DNA-free and UV-irradiated. · DNA extraction based on Boom's method: QIAGEN kit and EZ1 BioRobot · Broad-range 16S rRNA gene amplification · Amplicons: sequenced in both directions on an ABIPRISM 3100 analyser (Applied Bio systems, COURTABOEUF, France). · Cloning experiments for several sequences in one sample· Analysis of sequence: GenBank using the BLASTN program through the website of the National Centre of Biotechnology Information.· Internal control PCR: b-actin gene· Real time PCR: for the detection of mycobacteria and gonococcal arthritis- Potential implications: We could have chosen, like the majority of the studies published to date, to compare our molecular method with another method of diagnosis (culture, histology). However, there is not currently gold standard and the diagnosis of osteoarticular infections generally rests on an accumulation of arguments. The rule of the expert group is to determine, with less possible error, if each patient included will be "infected". This methodology is close to daily clinical reality and trusted in physician who was treating the patient. If the study shows an advantage of the molecular biology versus classical methods in our groups it would then be justified to discuss the diagnosis diagram of osteoarticular infections.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Spondylodiscitis control group | – | Procedure: Microbiological cultures and Molecular biologyPatients needing vertebral biopsy looking for tumoral etiology |
| Prosthetic Joint Infection control group | – | Procedure: Microbiological cultures and Molecular biologyPatients with primary prosthetic arthrosis surgery |
| Septic arthritis control group | – | Procedure: Microbiological cultures and Molecular biologyArthrosic patients needing evacuating articular punction with leucocytes infiltration less than 1000 /mm3 |
| Spondylodiscitis case group | – | Procedure: Microbiological cultures and Molecular biologyPatients suspected of Discitis and/or Vertebral Osteomyelitis is defined by the need of spinal biopsy in infectious context. |
| Prosthetic Joint Infection case group | – | Procedure: Microbiological cultures and Molecular biologyPatients suspected of Prosthetic Joint Infection defined by the need of surgical revision for diagnostic or therapeutic aiming in infectious context. |
| Septic arthritis case group | – | Procedure: Microbiological cultures and Molecular biologyPatients suspected of Septic arthritis without prosthesis were defined by the need of synovial punction and/or biopsy |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Suspected diagnosis of osteoarticular infections included discitis, septic arthritis and prosthetic joint infection and control patients.
Key inclusion criteria (39 listed)
- Patient are more than 18 years old
- Patient who do not declined to have his medical records reviewed for research
- Patients suspected of Discitis and/or Vertebral Osteomyelitis is defined by the need of spinal biopsy in infectious context. Spinal biopsies will be justified by one or more clinical or imaging findings:
- Clinical presentation
- Spinal pain unrelieved by rest
Key exclusion criteria (8 listed)
- Patients already include.
- Patient without health insurance
- Antibiotic treatment before sampling does not constitute an exclusion criterion
- Suspicion of concomitant infection defined by a fever >38°C and CRP > 10mg/l
- Arthrosis treated by infiltration in the 6 months which preceding inclusion
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Microbiological cultures and Molecular biologyBiological/Vaccine: Microbiological cultures and Molecular Biology Bacteriological procedures: All solid specimens will be crushed using a mechanic apparatus. Direct examination and cultures will be performed according to the guidelines applied for osteoarticular infections. Cultures and subcultures will be incubated for 15 days to 3 months for Mycobacteria. Molecular procedures: DNA extraction will be based on Boom's method (QIAGEN kit and EZ1 BioRobot). Detections of bacteria will be performed by amplification and sequencing of the 16S rRNA gene. Some specific detections as the detection of Staphylococcus sp. and Mycobacterium tuberculosis will be added to this protocol. | Procedure or surgery | Prosthetic Joint Infection case group, Prosthetic Joint Infection control group, Septic arthritis case group, Septic arthritis control group, Spondylodiscitis case group, Spondylodiscitis control group |
Primary outcome
Prosthetic Joint Infections, Vertebral Osteomyelitis and Septic arthritis: Frequency of detection with classical bacteriological methods and molecular methods
Time frame: Day 0
1 secondary outcome
Time of returned results by one or the other of the techniques
Time frame: up to 90 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jun 2014.
- Background: PubMed 18029022Fihman V, Hannouche D, Bousson V, Bardin T, Liote F, Raskine L, Riahi J, Sanson-Le Pors MJ, Bercot B. Improved diagnosis specificity in bone and joint infections using molecular techniques. J Infect. 2007 Dec;55(6):510-7. doi: 10.1016/j.jinf.2007.09.001. Epub 2007 Oct 29.
Related trials for Osteoarticular Infections
Not yet recruiting
All-Oral Fluoroquinolone-Based Triple Therapies for Adults With Imaging-Confirmed Osteoarticular Brucellosis
Brucellosis, Osteoarticular Brucellosis
RecruitingObservational study
Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)
Drug-Related Side Effects and Adverse Reactions, Treatment Adherence and Compliance
Recruiting
Population Pharmacokinetic Model of Rifampicin in Staphylococcal Osteoarticular Infections
Prosthetic Joint Infection, Osteomyelitis
Not yet recruitingPhase 3
Enhancing Amoxicillin Pharmacokinetics and Pharmacodynamics Parameters With Probenecid in Bone and Joint Infections
Osteoarticular Infections (OAIs)
RecruitingPhase 4
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Methicillin Resistant Staphylococcus Aureus, Osteomyelitis Acute
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Beatrice BERCOT, MD,PhD principal investigator
Assistance Publique - Hôpitaux de Paris
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoarticular Infections, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 39 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prosthetic Joint Infections, Vertebral Osteomyelitis and Septic arthritis: Frequency of detection with classical bacteriological methods and molecular methods (time frame: Day 0). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01193803, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2014.